House · HR 2483 · 119th Congress
SUPPORT for Patients and Communities Reauthorization Act of 2025
Sign in to cast a dissent vote.
Summary
This bill renews federal programs that fight drug addiction, overdoses, and mental health crises through 2030. It funds treatment for pregnant women, recovery support, first responder training, and youth prevention efforts. It also creates a new federal group to study fentanyl contamination and requires a review of scheduling rules for a common addiction treatment drug.
In Favor
Opioid overdoses still kill tens of thousands of Americans each year. This bill keeps proven programs running that train first responders, support people in recovery, and treat pregnant women with addiction. It also targets fentanyl contamination directly and could make a key addiction treatment drug easier to access by reviewing its controlled substance status.
Against
Renewing these programs costs over half a billion dollars per year with no guarantee the money produces better results. The bill extends funding for many programs without requiring proof that past spending worked. Communities and providers will also face new reporting and cybersecurity rules that add administrative work and cost without clear new resources to cover them.
Additional Considerations
Purpose & Problem
Is the problem real and worth federal action?
The bill renews federal programs that work to prevent, treat, and support recovery from substance use disorders, with a stated focus on opioids and related drug crises, for fiscal years 2026 through 2030.
Scope & Related Provisions
Does it stay focused, or carry unrelated add-ons?
Most sections stay on the substance use and mental health topic. The bill also adds cybersecurity reporting duties for the 988 Suicide Prevention Lifeline and requires guidance on at-home drug disposal systems, both tied to the broader public health focus.
Who Is Affected
Who benefits, and who bears the cost?
People with substance use disorders, pregnant women, youth, and first responders are among those the programs serve. Health care providers, states, Tribes, and nonprofits take on new reporting duties or become eligible for grants.
Cost & Funding
Is it affordable and responsibly funded?
The bill authorizes specific dollar amounts per year from 2026 through 2030 across many programs. Examples include $505,579,000 authorized per year for overdose prevention, $12,500,000 per year for fetal alcohol spectrum disorder programs, and $57,000,000 per year for first responder training. These are funds authorized, not a total cost estimate.
Risks & Implementation
What could go wrong in practice?
Many sections require federal agencies to write new guidance, conduct reviews, or convene meetings within set deadlines. Carrying out these tasks depends on agencies having enough staff and resources to meet each deadline written into the bill.
Major Provisions by Title
TITLE I--PREVENTION
This title renews and increases funding for several public health programs related to substance use and mental health prevention. It extends money for programs covering prenatal health, overdose prevention, fetal alcohol spectrum disorders, first responder training, and child trauma support through 2030. It also adds new rules for cybersecurity reporting by the 988 Suicide Prevention Lifeline, creates guidance for at-home drug disposal, and allows opioid response grants to cover fentanyl test strips.
TITLE II--TREATMENT
This title renews and increases funding for several treatment programs, including residential care for pregnant and postpartum women with substance use disorders, loan repayment for treatment workers, and mental health training grants. It also directs the government to review the drug scheduling of buprenorphine-naloxone combination products, update opioid overdose reversal drug references in grant programs, and study how electronic health records can improve mental health and substance use care. Additionally, it requires a review of how states use mental health block grant funds for people with serious mental illness and children with serious emotional disturbance.
TITLE III--RECOVERY
This title reauthorizes and increases funding for several recovery-focused programs through 2030, including community recovery support, peer support centers, opioid recovery centers, and youth prevention programs. It also expands workforce support grants for people in recovery, allows grant funds to cover transportation to work or treatment, and extends a recovery housing pilot program. Additionally, it requires the government to hold a public meeting and improve its websites to help organizations more easily find and apply for substance abuse funding.
TITLE IV--MISCELLANEOUS MATTERS
Section 401 updates the rules for how pharmacies can deliver certain controlled substances directly to prescribing doctors, adding drugs that require special safety monitoring programs to the list of allowed exceptions. Section 402 expands the list of medical and professional organizations whose training programs count toward the required education for prescribers of controlled substances, adding groups like family physicians, podiatrists, pharmacists, and psychiatric nurses. These changes apply as if they had been in place since December 29, 2022.
For the actual bill text, see congress.gov.
AI-generated · Published 6/6/2026